SKP2 and hepatocellular carcinoma: In hepatocellular carcinoma, in vitro and in vivo studies reveal that simvastatin induces G0/G1 arrest by upregulating p21 and p27, activating AMPK and inhibiting the STAT3-Skp2 axis in HCC (166).